Posts tagged regulation
No Significant Fraud: CMS findings relieve concerns over Medicare Telehealth during COVID
No Significant Fraud: CMS findings relieve concerns over Medicare Telehealth during COVID

Discover what the OIG found when investigating telehealth billing fraud, what they recommend regarding future CMS oversight, and four takeaways for businesses billing Medicare telehealth services.

Read More
Digital Health, Fraud and Abuse, Medical Practice, Medicare, OIG, Physician Fee Schedule, Regulations, Reimbursement, Remote Monitoring, Telehealth, Virtual Care, Virtual Care ManagementFaisal Khantelehealth, virtual care managemet, remote monitoring, oig, cms, fraud, Medicare claims, billing, risk management, audits, investigations, regulation
Digital Health Companies: How to choose a business model to bring your consumer-centric care to the market
Digital Health Companies: How to choose a business model to bring your consumer-centric care to the market
Digital Health, Life Sciences, Medical Practice, MSO, Physicians, Regulations, Reimbursement, Remote Monitoring, Remote Patient Monitoring, Telehealth, Telemedicine, Virtual Care ManagementRebecca GwiltDigital Health, regulation, Virtual care, business, market, Telehealth, Virtual care management, virtual care compliance, direct to consumer, friendly PC, friendly physician MSO, provider, healthcare provider, telehealth network, MSO, pharmacy, telepharmacy, mobile medical applications
Pharmacy Innovation Series: the DEA Steps into Telepharmacy Regulation
Pharmacy Innovation Series: the DEA Steps into Telepharmacy Regulation

For the first time, the Drug Enforcement Agency (“DEA”) is becoming directly involved in the telepharmacy space, an industry that the DEA has not previously regulated aside from the loose application of its existing regulations governing online pharmacies. Find out what this means for your business and how you can submit comments to the DEA directly in this post.

Read More
Life Sciences, Pharmacy, Telehealth, TelemedicineReema Tanejatelepharmacy, DEA, ANPRM, csa, controlled substances act, pharmacist, pharmacy, regulation